US Stock MarketDetailed Quotes

XBIOW Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com)

Watchlist
  • 17.5400
  • 0.00000.00%
Close Jul 18 16:00 ET
0Market Cap0.00P/E (TTM)

Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-5.16%-1.16M
11.46%-4.11M
-5.61%-793.03K
12.01%-949.63K
-74.11%-1.27M
47.19%-1.1M
1.93%-4.65M
48.52%-750.91K
-4.44%-1.08M
-0.29%-728.9K
Net income from continuing operations
-39.53%-1.2M
36.90%-4.13M
20.98%-1.17M
-31.29%-1.06M
60.67%-1.05M
46.25%-856.55K
-16.07%-6.55M
19.50%-1.48M
40.48%-804.02K
-141.46%-2.67M
Depreciation and amortization
----
--0
--0
--0
----
----
-23.78%27.04K
--0
-11.98%7.96K
9.89%9.61K
Other non cash items
----
----
----
----
----
----
--1.79M
--488.75K
--0
----
Change In working capital
86.88%-41.31K
38.43%-262.73K
144.63%303.9K
108.48%35.66K
-158.35%-287.55K
49.49%-314.74K
-192.52%-426.69K
-52.33%124.23K
-313.12%-420.57K
88.67%492.81K
-Change in prepaid assets
116.16%51.79K
53.99%-47.73K
469.94%876.73K
-232.75%-161.53K
-261.48%-442.5K
-22.10%-320.45K
-136.27%-103.74K
-168.00%-236.99K
291.48%121.67K
147.34%274.02K
-Change in payables and accrued expense
57.06%-93.09K
24.25%-263.57K
-1,261.14%-258.91K
186.36%197.18K
-93.08%14.95K
39.42%-216.79K
-176.12%-347.95K
-92.56%22.3K
-247.00%-228.33K
43.55%215.92K
-Change in other current assets
--0
94.32%48.58K
-192.62%-313.92K
--0
4,776.35%140K
7,849.91%222.5K
108.87%25K
187.46%338.92K
---313.92K
--2.87K
Cash from discontinued investing activities
Operating cash flow
-5.16%-1.16M
11.46%-4.11M
-5.61%-793.03K
12.01%-949.63K
-74.11%-1.27M
47.19%-1.1M
1.93%-4.65M
48.52%-750.91K
-4.44%-1.08M
-0.29%-728.9K
Investing cash flow
Cash flow from continuing investing activities
0
0
0
-500K
0
0
Net intangibles purchase and sale
----
--0
--0
--0
----
----
---500K
--0
--0
----
Cash from discontinued investing activities
Investing cash flow
----
--0
--0
--0
----
----
---500K
--0
--0
----
Financing cash flow
Cash flow from continuing financing activities
Cash from discontinued financing activities
Net cash flow
Beginning cash position
-31.41%8.98M
-28.21%13.1M
-29.41%9.78M
-28.15%10.73M
-25.76%11.99M
-28.21%13.1M
58.26%18.24M
-29.71%13.85M
60.83%14.93M
61.43%16.16M
Current changes in cash
-5.16%-1.16M
20.06%-4.11M
-5.61%-793.03K
12.01%-949.63K
-3.27%-1.27M
47.19%-1.1M
-176.63%-5.15M
48.52%-750.91K
-110.36%-1.08M
-69.08%-1.23M
End cash Position
-34.77%7.82M
-31.41%8.98M
-31.41%8.98M
-29.41%9.78M
-28.15%10.73M
-25.76%11.99M
-28.21%13.1M
-28.21%13.1M
-29.71%13.85M
60.83%14.93M
Free cash flow
-5.16%-1.16M
20.06%-4.11M
-5.61%-793.03K
12.01%-949.63K
-3.27%-1.27M
47.19%-1.1M
-8.63%-5.15M
48.52%-750.91K
-4.44%-1.08M
-69.08%-1.23M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -5.16%-1.16M11.46%-4.11M-5.61%-793.03K12.01%-949.63K-74.11%-1.27M47.19%-1.1M1.93%-4.65M48.52%-750.91K-4.44%-1.08M-0.29%-728.9K
Net income from continuing operations -39.53%-1.2M36.90%-4.13M20.98%-1.17M-31.29%-1.06M60.67%-1.05M46.25%-856.55K-16.07%-6.55M19.50%-1.48M40.48%-804.02K-141.46%-2.67M
Depreciation and amortization ------0--0--0---------23.78%27.04K--0-11.98%7.96K9.89%9.61K
Other non cash items --------------------------1.79M--488.75K--0----
Change In working capital 86.88%-41.31K38.43%-262.73K144.63%303.9K108.48%35.66K-158.35%-287.55K49.49%-314.74K-192.52%-426.69K-52.33%124.23K-313.12%-420.57K88.67%492.81K
-Change in prepaid assets 116.16%51.79K53.99%-47.73K469.94%876.73K-232.75%-161.53K-261.48%-442.5K-22.10%-320.45K-136.27%-103.74K-168.00%-236.99K291.48%121.67K147.34%274.02K
-Change in payables and accrued expense 57.06%-93.09K24.25%-263.57K-1,261.14%-258.91K186.36%197.18K-93.08%14.95K39.42%-216.79K-176.12%-347.95K-92.56%22.3K-247.00%-228.33K43.55%215.92K
-Change in other current assets --094.32%48.58K-192.62%-313.92K--04,776.35%140K7,849.91%222.5K108.87%25K187.46%338.92K---313.92K--2.87K
Cash from discontinued investing activities
Operating cash flow -5.16%-1.16M11.46%-4.11M-5.61%-793.03K12.01%-949.63K-74.11%-1.27M47.19%-1.1M1.93%-4.65M48.52%-750.91K-4.44%-1.08M-0.29%-728.9K
Investing cash flow
Cash flow from continuing investing activities 000-500K00
Net intangibles purchase and sale ------0--0--0-----------500K--0--0----
Cash from discontinued investing activities
Investing cash flow ------0--0--0-----------500K--0--0----
Financing cash flow
Cash flow from continuing financing activities
Cash from discontinued financing activities
Net cash flow
Beginning cash position -31.41%8.98M-28.21%13.1M-29.41%9.78M-28.15%10.73M-25.76%11.99M-28.21%13.1M58.26%18.24M-29.71%13.85M60.83%14.93M61.43%16.16M
Current changes in cash -5.16%-1.16M20.06%-4.11M-5.61%-793.03K12.01%-949.63K-3.27%-1.27M47.19%-1.1M-176.63%-5.15M48.52%-750.91K-110.36%-1.08M-69.08%-1.23M
End cash Position -34.77%7.82M-31.41%8.98M-31.41%8.98M-29.41%9.78M-28.15%10.73M-25.76%11.99M-28.21%13.1M-28.21%13.1M-29.71%13.85M60.83%14.93M
Free cash flow -5.16%-1.16M20.06%-4.11M-5.61%-793.03K12.01%-949.63K-3.27%-1.27M47.19%-1.1M-8.63%-5.15M48.52%-750.91K-4.44%-1.08M-69.08%-1.23M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data